Searched for
GLAND PHARMA SHARES
IEX shares rise 2% after electricity trading volume jumps 20% YoY to hit record high in AugustIEX shares rose on Friday after the exchange reported record monthly electricity trading volume of 13,938 MUs in August, up 20.2% year-on-y...- Large trade alert! Gland Pharma shares fall 3% after 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell 3% after 1.22 crore shares changed hands in two block deals worth nearly Rs 5,818 crore. Promoter Fosun Pharma Ind...
- Block deal alert! Gland Pharma shares fall 3% as 1.2 crore shares change hands in 2 block deals; promoter Fosun likely sellerGland Pharma shares fell after a significant block deal involving Fosun Pharma Industrial. The company's VSEZ facility received zero USFDA ...
- Stocks in news: HDFC Bank, M&M, Gland Pharma, CreditAccess Grameen and Bharat ForgeIndian benchmark indices extended their losing streak for a fourth consecutive session on Thursday. Nifty 50 fell 0.17% and Sensex declined...
- Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...
- INDO-MIM, Ather Energy and TCS among stocks bought and sold by mutual funds in JulyMutual funds bought Rs 15,900 crore of stocks in July while FIIs sold Rs 11,000 crore. Axis Bank, INDO-MIM and Kotak Mahindra Bank saw majo...
- Ahead of Market: 10 things that will decide stock market action on WednesdayIndian equities declined as rising crude prices and a weaker rupee weighed on sentiment. Sensex fell 388 points and Nifty 112 points, while...
- Gland Pharma shares rally 12% after Q1FY27 profit jumps 47% YoY. Should you buy, sell or hold?Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth promp...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Dividend alert: Jio Financial, Power Grid, HPCL among 90 stocks turning ex-dividend this weekNearly 90 companies, including Jio Financial Services, Power Grid Corporation, HPCL, and Hindustan Aeronautics, will turn ex-dividend betwe...
- PCBL Chemical among 4 stocks closing above VWAP, signalling bullish shiftFour Nifty500 stocks, including PCBL Chemical, Blue Jet Healthcare, Gland Pharma, and International Gemological Institute, closed above the...
- Reliance Industries, Groww and MTAR Technologies among stocks bought and sold by mutual funds in JuneMutual funds invested Rs 50,600 crore in stocks during June. They significantly bought JSWInfra, Bajaj Finance, and HDFC Bank. Conversely, ...
- Quant Small Cap Fund exits RIL, 8 others; raises exposure to two Adani stocks. Check full listQuant Small Cap Fund made a major portfolio reshuffle in June, exiting Reliance Industries and eight other stocks while increasing exposure...
- Cemindia Projects among 8 small-cap stocks that hit 52-week highs, rally up to 35% in a monthDespite a weak broader market, eight BSE Small-cap 250 stocks, led by Cemindia Projects, hit fresh 52-week highs after rallying up to 35% o...
- Two Trades for Today: An auto sector major for a 6.25% upmove, a mid-cap pharma stock for a gain of almost 7%Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...
- Gland Pharma shares rally 6% as brokerages lift ratings, target prices; here's whyGland Pharma shares surged after strong Q1 results and positive commentary from brokerages citing a turnaround at its European unit Cenexi....
- Gland Pharma shares fall over 4% after weak Q3 result, Jefferies target price cutGland Pharma share price: Revenue from operations fell 10% year-on-year to Rs 1,384 crore. EBITDA increased by 1% year-on-year to Rs 360 cr...
- Gland Pharma shares climb over 6% post Q2 results. Should you buy or sell?Meanwhile, the company's earnings before interest, taxes, depreciation and amortization (EBITDA) came in at Rs 320.5 crore, up from Rs 297 ...
- Gland Pharma shares tank 19%, hit 52-week low as Q4 earning weighsGland Pharma shares reached a 52-week low of Rs 861 on May 24th, falling for the fifth consecutive day. The fall comes after the company re...
- Smartkarma Research: APAC Healthcare Series - Top picks are poised for multi-year growthGland Pharma’s near-term focus remains on establishing a strong portfolio of complex injectables. The company is working on development of ...
Load More
